Gitte L. Pedersen has more than 20 years of management experience in the biotech and pharma industry. She has held a number of executive positions at NovoZymes, where she successfully developed and launched new products worldwide. In 1997 she established an advisory firm, Proximity Ventures, and in that capacity, she has advised a number of biotech and government institutions resulting in numerous licensing and equity deals with companies such as GSK, JnJ, Merck, P&G, Wyeth, and Takeda. Her aggregated deal resume is more than $1 billion. Gitte Pedersen is the co-founder of Genomic Expression and has served as its CEO since 2009. Gitte has a masters in chemical engineering and a business degree.
Transcriptomics and Genomics